Reticulocytosis is not seen in which diseases?
Apr 04, 2023
Source: Cainiu Health
Dr. Liu Feng
Introduction
Under normal circumstances, reticulocytosis is not seen in diseases such as iron deficiency anemia, rheumatic disorders, aplastic anemia, chronic renal failure, and leukemia. Iron deficiency anemia, the most common type of anemia, results from inadequate intake or poor absorption of iron. Reticulocytosis is uncommon in pure iron deficiency anemia.
Under normal circumstances, reticulocytosis is not observed in conditions such as iron deficiency anemia, rheumatic diseases, aplastic anemia, chronic renal failure, and leukemia. The details are as follows:
1. Iron Deficiency Anemia
Iron deficiency anemia is the most common type of anemia, caused by insufficient intake or poor absorption of iron. Although anemia may stimulate the bone marrow to produce more reticulocytes, significant reticulocytosis is uncommon in pure iron deficiency anemia.
2. Rheumatic Diseases
Rheumatic diseases may be triggered by immune responses, endocrine factors, genetic predisposition, infections, and environmental factors. These conditions may lead to changes in biochemical markers but do not cause reticulocytosis.
3. Aplastic Anemia
Aplastic anemia is generally associated with drug exposure, viral infections, or genetic factors, leading to impaired bone marrow hematopoietic function and reduced blood cell production. This results in symptoms such as dizziness, fever, and skin hemorrhage. Patients may benefit from allogeneic hematopoietic stem cell transplantation at a qualified medical center.
4. Chronic Renal Failure
Chronic renal failure leads to a deficiency in erythropoietin, a hormone involved in red blood cell production. In patients with kidney failure, this lack of erythropoietin typically causes the bone marrow to produce fewer red blood cells rather than increased reticulocytes.
5. Leukemia
Leukemia is a malignant clonal disorder of hematopoietic stem cells in the bone marrow. Although leukemia disrupts normal hematopoiesis and may affect reticulocyte production, it does not necessarily result in marked reticulocytosis. Blood tests in leukemia patients may reveal other abnormal findings.
In summary, if patients experience any discomfort or symptoms, they should seek timely medical evaluation at a hospital to determine the underlying condition and receive appropriate treatment, avoiding delays in diagnosis and management.
